Explore the fascinating stories behind 11 iconic vintage car logos. Learn how design, history, and identity shaped these timeless automotive symbols.

Walgreens CEO discusses the ongoing struggle with theft prevention in stores, citing locking items as ineffective.

CNET’s expert staff reviews and rates dozens of new products and services each month, building on more than a quarter century of expertise.

Giftify (GIFT) announces its white label partnership with CVS, powering their CVS Gift Card Exchange is now entering its 2nd year. Ketan Thakker, Chief Executive Officer of Giftify, Inc ...

The Target logo is a distinctive and recognisable symbol of the brand. It consists of a bold, red bullseye design on a white background. The bullseye is ... appeal while maintaining its core elements.

CVS announced CostVantage in late 2023 as its ... PBMs had a financially rich but politically bruising 2024, emerging as public enemy No. 1 in the fight over who to blame for skyrocketing drug ...

CVS announced CostVantage in late 2023 as its pharmacies struggled ... PBMs had a financially rich but politically bruising 2024, emerging as public enemy No. 1 in the fight over who to blame for ...

Unlike other background checks, there’s no paywall stopping you from accessing some of the data, so you’ll only pay if you want to open up the full and more detailed report. When the time ...

CVS Pharmacy Inc. is being sued by the U.S. Department of Justice for allegedly filling illegal prescriptions and seeking reimbursement from federal health care programs for unlawful medications. CVS, ...

The Justice Department has unsealed a civil complaint alleging CVS Pharmacy Inc. and various subsidiaries filled unlawful prescriptions in violation of the federal Controlled Substances Act. Wednesday ...

The Justice Department has unsealed a civil complaint alleging CVS Pharmacy Inc. and various subsidiaries filled unlawful prescriptions in violation of the federal Controlled Substances Act.

Evercore ISI analyst Elizabeth Anderson CFA maintained a Buy rating on CVS Health (CVS – Research Report) today and set a price target of $75.00. The company’s shares opened today at $44.80.